Mesocortical dopaminergic dysfunction in Parkinson's disease-depression: Evidence from a 123I-FP-CIT SPECT investigation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of the Neurological Sciences

• Publication date

  2013-10-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.JNS.2013.07.532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease

  2013cited by this paper
• Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

  2013cited by this paper
• Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses.

  2012cited by this paper
• Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction

  2012cited by this paper
• Higher dopamine transporter density in Parkinson’s disease patients with depression

  2010cited by this paper
• Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• Regional patterns of brain tissue loss associated with depression in Parkinson disease

  2010cited by this paper
• Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease

  2008cited by this paper
• Depression in Parkinson’s disease

  2007cited by this paper
• The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation

  2007cited by this paper
• Dementia in Parkinson’s disease: diffusion tensor imaging

  2007cited by this paper
• Dopamine transporter binding in depressed patients with anhedonia.

  2006cited by this paper
• Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

  2005cited by this paper
• Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

  2005cited by this paper
• Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.

  2003cited by this paper
• Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.

  2002cited by this paper
• Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

  2002cited by this paper
• Subgenual prefrontal cortex abnormalities in mood disorders

  1997cited by this paper
• Depression in Parkinson's Disease

  1994cited by this paper
• Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody.

  1993cited by this paper
• The association of ventral tegmental area histopathology with adult dementia.

  1988cited by this paper

• No citing papers are available for this paper.